Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice

Journal of Clinical Investigation

Volumn 117, Issue 12, 2007, Pages 3900-3908

  Yvan Charvet, Laurent ^a,b   Ranalletta, Mollie ^a   Wang, Nan ^a   Han, Seongah ^a   Terasaka, Naoki ^a   Li, Rong ^a   Welch, Carrie ^a   Tall, Alan R ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ESTERIFICATION; FOAM CELL; GAS LIQUID CHROMATOGRAPHY; GENE EXPRESSION; LIPID OXIDATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; FOAM CELLS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MICE; MICE, KNOCKOUT; MYOCARDIUM; SPLEEN;

EID: 36849011221     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33372     Document Type: Article

References (60)

1. Gordon, D.J., and Rifkind, B.M. 1989. High-density lipoprotein-the clinical implications of recent studies. N. Engl. J. Med. 321:1311-1316.
2. Glomset, J.A. 1968. The plasma lecithins:cholesterol acyltransferase reaction. J. Lipid Res. 9:155-167.
3. Plump, A.S., Scott, C.J., and Breslow, J.L. 1994. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. U. S. A. 91:9607-9611.
4. Kontush, A., and Chapman, M.J. 2006. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58:342-374.
5. Ross, R. 1999. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:115-126.
6. Phillips, M.C., et al. 1998. Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Atherosclerosis. 137(Suppl.):S13-S17.
7. Huang, Z.H., Fitzgerald, M.L., and Mazzone, T. 2006. Distinct cellular loci for the ABCA1-dependent and ABCA1-independent lipid efflux mediated by endogenous apolipoprotein E expression. Arterioscler. Thromb. Vasc. Biol. 26:157-162.
8. Langer, C., et al. 2000. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid free apolipoproteins in mouse peritoneal macrophages. J. Mol. Med. 78:217-227.
9. Ji, Y., et al. 1997. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J. Biol. Chem. 272:20982-20985.
10. Tall, A.R., Costet, P., and Wang, N. 2002. Regulation and mechanisms of macrophage cholesterol efflux. J. Clin. Invest. 110:899-904. doi:10.1172/JCI200216391.
11. Zannis, V.I., Chroni, A., and Krieger, M. 2006. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J. Mol. Med. 84:276-294.
12. Wang, N., Silver, D.L., Costet, P., and Tall, A.R. 2000. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275:33053-33058.
13. Oram, J.F., Lawn, R.M., Garvin, M.R., and Wade, D.P. 2000. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275:34508-34511.
14. Wang, N., Lan, D., Chen, W., Matsuura, F., and Tall, A.R. 2004. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to highdensity lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 101:9774-9779.
15. Brooks-Wilson, A., et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:336-345.
16. Bodzioch, M., et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22:347-351.
17. Rust, S., et al. 1999. Tangier disease is caused by mutations in the gene encoding ATP binding cassette transporter 1. Nat. Genet. 22:352-355.
18. Clee, S.M., et al. 2001. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation. 103:1198-1205.
19. Aiello, R.J., et al. 2002. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 22:630-637.
20. van Eck, M., et al. 2002. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. U. S. A. 99:6298-6303.
21. Joyce, C.W., et al. 2002. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc. Natl. Acad. Sci. U. S. A. 99:407-412.
22. Singaraja, R.R., et al. 2002. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 110:35-42. doi:10.1172/ JCI200215748.
23. Kennedy, M.A., et al. 2005. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 1:121-131.
24. Out, R., et al. 2006. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26:2295-2300.
25. -/- bone marrow. Arterioscler. Thromb. Vasc. Biol. 26:2308-2315.
26. -/- bone marrow. Arterioscler. Thromb. Vasc. Biol. 26:2301-2307.
27. Linton, M.F., Atkinson, J.B., and Fazio, S. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267:1034-1037.
28. Mahley, R.W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:622-630.
29. Fazio, S., et al. 1997. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc. Natl. Acad. Sci. U. S. A. 94:4647-4652.
30. Wang, X., et al. 2007. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 117:2216-2224. doi:10.1172/JCI32057.
31. Von Eckardstein, A., et al. 2001. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J. 15:1555-1561.
32. Yancey, P.G., Yu, H., Linton, M.F., and Fazio, S. 2007. A pathway-dependent on apoE, ApoAI, and ABCA1 determines formation of buoyant high-density lipoprotein by macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 27:1123-1131.
33. Laffitte, B., et al. 2001. LXRs control lipid-inductible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. U. S. A. 98:507-512.
34. Tabas, I. 2002. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110:905-911. doi:10.1172/JCI200216452.
35. Aikawa, M., and Libby, P. 2004. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc. Pathol. 13:125-138.
36. Costet, P., Luo, Y., Wang, N., and Tall, A.R. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid receptor. J. Biol. Chem. 275:28240-28245.
37. Venkateswaran, A., et al. 2000. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. J. Biol. Chem. 275:14700-14707.
38. Hayden, M.R., et al. 2000. Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency. Curr. Opin. Lipidol. 11:117-122.
39. Francis, G.A., Knopp, R.H., and Oram, J.F. 1995. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest. 96:78-87.
40. Chen, W., et al. 2001. Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J. Biol. Chem. 276:43564-43569.
41. Basso, F., et al. 2006. Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet. Biochem. Biophys. Res. Commun. 351:398-404.
42. Zhang, W., et al. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein Edeficient mice. Circulation. 108:2258-2263.
43. Brundert, M., et al. 2006. Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BI. J. Lipid Res. 47:2408-2117.
44. Gelissen, I.C., et al. 2006. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol. 26:534-540.
45. Vaughan, A.M., and Oram, J.F. 2006. ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL. J. Lipid Res. 47:2433-2443.
46. Chen, W., Silver, D.L., Smith, J.D., and Tall, A.R. 2000. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages. J. Biol. Chem. 275:30794-30800.
47. Curtiss, L.K., and Boisvert, W.A. 2000. Apolipoprotein E and atherosclerosis. Curr. Opin. Lipidol. 11:243-251.
48. Terasaka, N., Wang, N., Yvan-Charvet, L., and Tall, A.R. 2007. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc. Natl. Acad. Sci. U. S. A. 104:15093-15098.
49. Arai, S., et al. 2005. A role for the apoptosis inhibitory factor AIM/Sp alpha/Api6 in atherosclerosis development. Cell Metab. 1:201-213.
50. Wolpe, S.D., and Cerami, A. 1989. Macrophage inflammatory proteins 1 and 2: members of a novel supergene of cytokines. FASEB J. 3:2565-2573.
51. Li, Y., et al. 2005. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NFkappaB-and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280:21763-21772.
52. Linsel-Nitschke, P., and Tall, A.R. 2005. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug Discov. 4:193-205.
53. Rader, D.J. 2007. Mechanisms of disease: HDL metabolism as a target for novel therapies. Nat. Clin. Pract. Cardiovasc. Med. 4:102-109.
54. Matsuura, F., Wang, N., Chen, W., Jiang, X.C., and Tall, A.R. 2006. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J. Clin. Invest. 116:1435-1442. doi:10.1172/JCI27602.
55. Tall, A.R. 2007. CETP inhibitors to increase HDL cholesterol levels. N. Engl. J. Med. 356:1364-1366.
56. Christiansen-Weber, T.A., et al. 2000. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am. J. Pathol. 157:1017-1029.
57. Han, S., et al. 2006. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 3:257-266.
58. Arai, T., Wang, N., Bezouevski, M., Welch, C., and Tall, A.R. 1999. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J. Biol. Chem. 274:2366-2371.
59. Van Eck, M., Bos, I.S., Hildebrand, R.B., Van Rij, B.T., and Van Berkel, T.J. 2004. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerosis lesion development. Am. J. Pathol. 165:785-794.
60. Vikramadithyan, R.K., et al. 2005. Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J. Clin. Invest. 115:2434-2443. doi:10.1172/JCI24819.